| Identification | Back Directory | [Name]
Mal-PEG4-VA-PBD | [CAS]
1342820-68-1 | [Synonyms]
Mal-PEG4-VA-SG3132
L-Alaninamide, N-[19-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1,17-dioxo-4,7,10,13-tetraoxa-16-azanonadec-1-yl]-L-valyl-N-[4-[(11aS)-8-[3-[[(11aS)-5,11a-dihydro-7-methoxy-2-(4-methoxyphenyl)-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]propoxy]-5,11a-dihydro-7-methoxy-5-oxo-1H-pyrrolo[2,1-c][1,4... | [Molecular Formula]
C68H79N9O17 | [MDL Number]
MFCD32661881 | [MOL File]
1342820-68-1.mol | [Molecular Weight]
1294.41 |
| Hazard Information | Back Directory | [Uses]
Mal-PEG4-VA-PBD is a agent-linker conjugate for ADC by using the antitumor antibiotic, Pyrrolobenzodiazepine (PBD), linked via Mal-PEG4-VA. | [IC 50]
Pyrrolobenzodiazepines |
|
|